Earnings Call · Q4 FY2023·2024-02-28

Q4 23EPS +9.86%·Rev n/aQ3 23EPS +2.06%·Rev n/aQ2 23EPS +11.82%·Rev n/aQ1 23EPS -6.03%·Rev n/a⚠ consensus missing

Natera, Inc. NTRA

Michael Brophy — Chief Financial Officer

Steve Chapman — Chief Executive Officer

Solomon Moshkevich — President, Clinical Diagnostics

Alexey Aleshin — General Manager of Oncology and Chief Medical Officer

+1.9%1d on move date+2.1% vs SPY3d−2.8%5d−3.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NTRA calls or request research access.

More NTRA calls Browse calls Request research access